V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20194012 | 20124472 | 1.69 | 67.2 | Palliative (P) | 2019-01-25 | 2019-01-30 | Docetaxel | 02 | N | DOCETAXEL | 100167521 |
| 20194013 | 20124473 | 1.83 | 68 | Palliative (P) | 2016-10-09 | 2016-10-29 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101641430 |
| 20194014 | 20124474 | 1.74 | 68 | Palliative (P) | 2016-11-27 | 2017-01-04 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101629462 |
| 20194017 | 20124475 | 1.53 | 85.8 | Palliative (P) | 2016-05-16 | 2016-05-19 | Docetaxel | 02 | N | DOCETAXEL | 100694540 |
| 20194020 | 20124476 | 1.76 | 53 | 02 | 2017-09-24 | 2017-09-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100308711 |
| 20194023 | 20124477 | 1.55 | 78.8 | Adjuvant (A) | 2020-08-14 | 2020-09-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101213792 |
| 20194030 | 20124478 | 1.59 | 65 | Palliative (P) | 2018-01-30 | 2018-03-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100541954 |
| 20194033 | 20124479 | 1.83 | 105 | Palliative (P) | 2016-12-26 | 2016-12-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101821314 |
| 20194034 | 20124480 | 0 | 69.1 | Palliative (P) | 2019-03-16 | 2019-03-25 | Docetaxel | 02 | N | DOCETAXEL | 100804171 |
| 20194039 | 20124481 | 1.76 | 45 | null | 2017-03-08 | 2017-10-18 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101842801 |
| 20194041 | 20124482 | 1.85 | 66.4 | null | 2019-12-15 | 2020-01-22 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101517021 |
| 20194043 | 20124483 | 1.67 | 57.4 | null | 2017-04-17 | 2017-05-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100947585 |
| 20194044 | 20124484 | 1.66 | 63.2 | null | 2020-02-03 | 2020-02-03 | Docetaxel | 02 | null | DOCETAXEL | 101389015 |
| 20194045 | 20124485 | 1.88 | 70.4 | Palliative (P) | 2016-10-20 | 2016-11-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101675456 |
| 20194046 | 20124486 | 1.66 | 63.2 | Palliative (P) | 2019-12-28 | 2020-01-11 | Cetuximab + FOLFIRI cycle1 | 02 | N | CAPECITABINE + GEMCITABINE | 100724103 |
| 20194048 | 20124487 | 1.52 | 68.9 | Palliative (P) | 2017-09-24 | 2020-05-16 | Docetaxel | 02 | N | DOCETAXEL | 100251924 |
| 20194052 | 20124488 | 1.6 | 49.6 | 03 | 2017-09-28 | 2017-09-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101806820 |
| 20194054 | 20124489 | 1.68 | 85.55 | null | 2017-06-06 | 2017-06-16 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100309911 |
| 20194061 | 20124490 | 1.77 | 40 | null | 2018-09-18 | 2018-09-23 | Docetaxel | 02 | null | DOCETAXEL | 101003215 |
| 20194065 | 20124491 | 1.7 | 65.5 | Palliative (P) | 2019-07-14 | 2019-07-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100034243 |
| 20194070 | 20124492 | 1.76 | 55.8 | Palliative (P) | 2019-12-14 | 2019-12-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100207088 |
| 20194077 | 20124493 | 1.76 | 63 | Palliative (P) | 2018-05-13 | 2018-05-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100828321 |
| 20194086 | 20124494 | 1.85 | 45 | Palliative (P) | 2019-12-30 | 2020-04-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100100772 |
| 20194088 | 20124495 | 1.8 | 75 | null | 2016-09-10 | 2016-09-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100562874 |
| 20194089 | 20124496 | 1.74 | 53.25 | Palliative (P) | 2019-12-22 | 2020-04-04 | CETUXIMAB + IRINOTECAN + MDG | N | N | DOCETAXEL | 100342461 |
| 20194091 | 20124497 | 1.7 | 101 | null | 2017-01-04 | 2017-08-29 | Gemcitabine + Capecitabine | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100575112 |
| 20194092 | 20124498 | 1.76 | 53 | null | 2016-09-30 | 2016-10-12 | Docetaxel | 02 | null | DOCETAXEL | 101667104 |
| 20194097 | 20124499 | 1.6 | 67.6 | Palliative (P) | 2018-04-09 | 2018-04-10 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100496922 |
| 20194101 | 20124500 | 1.6 | 68 | null | 2019-09-28 | 2019-09-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100922688 |
| 20194105 | 20124501 | 1.65 | 85 | Palliative (P) | 2016-12-11 | 2016-12-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101506413 |
| 20194107 | 20124502 | 1.82 | 81.75 | Palliative (P) | 2019-04-06 | 2019-04-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101581983 |
| 20194110 | 20124503 | 1.69 | 53.25 | null | 2017-08-28 | 2017-09-08 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100146066 |
| 20194111 | 20124504 | 1.67 | 102 | null | 2016-07-07 | 2016-07-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101864141 |
| 20194118 | 20124505 | 1.69 | 97.2 | Palliative (P) | 2018-11-01 | 2018-11-05 | Docetaxel | 02 | N | DOCETAXEL | 100342517 |
| 20194124 | 20124506 | 1.67 | 106 | Palliative (P) | 2019-05-14 | 2019-06-26 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100793840 |
| 20194129 | 20124507 | 1.88 | 59.5 | Palliative (P) | 2017-09-11 | 2017-09-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100935975 |
| 20194132 | 20124508 | 1.76 | 79.7 | Palliative (P) | 2019-05-21 | 2019-06-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101170207 |
| 20194133 | 20124509 | 1.76 | 71 | Adjuvant (A) | 2020-01-28 | 2020-02-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100209061 |
| 20194135 | 20124510 | 1.61 | 91 | Palliative (P) | 2021-07-10 | 2021-10-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100744701 |
| 20194136 | 20124511 | 1.7 | 80.3 | null | 2019-06-12 | 2019-07-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100229269 |
| 20194137 | 20124512 | 1.44 | 60.1 | Palliative (P) | 2016-10-26 | 2016-11-07 | Docetaxel | 02 | N | DOCETAXEL | 101691585 |
| 20194138 | 20124513 | 0 | 63.2 | null | 2020-06-08 | 2020-06-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100548290 |
| 20194139 | 20124514 | 1.81 | 64.4 | null | 2020-07-31 | 2020-08-16 | Docetaxel | 02 | null | DOCETAXEL | 100996751 |
| 20194141 | 20124515 | 0 | null | Palliative (P) | 2017-12-25 | 2018-01-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101192086 |
| 20194148 | 20124516 | 1.55 | 102.4 | null | 2016-10-05 | 2016-10-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 101506856 |
| 20194149 | 20124517 | 1.63 | 76.4 | 03 | 2022-02-06 | 2022-02-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101590022 |
| 20194153 | 20124518 | 1.67 | 70.6 | Adjuvant (A) | 2016-09-24 | 2016-10-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100530306 |
| 20194154 | 20124519 | 1.66 | 87.7 | Palliative (P) | 2017-02-13 | 2017-04-09 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100300820 |
| 20194169 | 20124520 | null | 92 | Palliative (P) | 2018-02-23 | 2018-04-21 | Docetaxel | 02 | N | DOCETAXEL | 101044342 |
| 20194172 | 20124521 | 1.7 | 82.2 | null | 2019-10-05 | 2019-10-16 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100352389 |